Insys Therapeutics Inc. (INSY) Stock Price & Overview
NASDAQ:INSY
Current stock price
The current stock price of INSY is 0.2911 null. Today INSY is down by -1.36%. In the past month the price decreased by -69.62%. In the past year, price decreased by -96.43%.
INSY Key Statistics
- Market Cap
- 21.707M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -1.74
- Dividend Yield
- N/A
INSY Stock Performance
INSY Stock Chart
INSY Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to INSY. When comparing the yearly performance of all stocks, INSY is a bad performer in the overall market: 99.94% of all stocks are doing better.
INSY Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to INSY. Both the profitability and financial health of INSY have multiple concerns.
INSY Earnings
INSY Forecast & Estimates
INSY Financial Highlights
Over the last trailing twelve months INSY reported a non-GAAP Earnings per Share(EPS) of -1.7400000000000002. The EPS decreased by -145.07% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -346.48% | ||
| ROA | -132.09% | ||
| ROE | 139.25% | ||
| Debt/Equity | -0.07 |
INSY Ownership
About INSY
Company Profile
Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray and Dronabinol SG capsule. Insys Therapeutics, Inc. is based in Phoenix, Arizona.
Company Info
Insys Therapeutics Inc.
1333 S. Spectrum Blvd Suite 100
Chandler AZ 85286
CEO: Saeed Motahari
Phone: 480-500-3127
Insys Therapeutics Inc. / INSY FAQ
What does Insys Therapeutics Inc. do?
Insys Therapeutics, Inc. is a commercial-stage specialty pharmaceutical company. It is engaged in the development and commercialization of pharmaceutical products that target the unmet needs of cancer patients, with an initial focus on cancer-supportive care. The company's cancer-supportive care and cancer therapy product candidates include Fentanyl sublingual spray and Dronabinol SG capsule. Insys Therapeutics, Inc. is based in Phoenix, Arizona.
What is the current price of INSY stock?
The current stock price of INSY is 0.2911 null. The price decreased by -1.36% in the last trading session.
Does Insys Therapeutics Inc. pay dividends?
INSY does not pay a dividend.
How is the ChartMill rating for Insys Therapeutics Inc.?
INSY has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
How is the valuation of Insys Therapeutics Inc. (INSY) based on its PE ratio?
Insys Therapeutics Inc. (INSY) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.74).